Carlsmed, Inc. Common Stock (CARL) Stock Forecast & Price Target
Carlsmed, Inc. Common Stock · NASDAQ
$12.37+0.92 (+8.03%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Carlsmed, Inc. Common Stock, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $17.00 to $23.00, so the covering firms are broadly aligned. The average target of $18.60 sits 50% above the current $12.37. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.40 next quarter toward $-1.44 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Carlsmed, Inc. Common Stock.
As of Jul, 5 of 5 firms rate CARL a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CARL EPS & revenue forecast
EPS · NEXT QUARTER
$-0.40
Range $-0.43 – $-0.36 · 2 analysts · +7% YoY
Next period, 2 analysts expect Carlsmed, Inc. Common Stock to earn $-0.40 a share (range $-0.43 – $-0.36), versus $-0.37 a year earlier. Full-year consensus is $-1.47, growing to $-1.44 the year after.
REVENUE · NEXT QUARTER
$18.9M
Range $18.4M – $19.4M · 2 analysts · +45% YoY
Revenue is expected to reach $18.9M (range $18.4M – $19.4M), +44.5% year-over-year. Full-year consensus is $74.8M, rising to $105.0M next year.
Top analysts covering Carlsmed, Inc. Common Stock
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CARL.
#1
David Saxon
Needham · Rank #264
Buy
$17.00+37.4% to target
Overall win rate
34%
+ Follow
#2
Matt O'Brien
Piper Sandler · Rank #356
Buy
$18.00+45.5% to target
Overall win rate
25%
+ Follow
#3
Ryan Zimmerman
BTIG
Buy
$23.00+85.9% to target
Coverage
—
+ Follow
#4
David Roman
Goldman Sachs
Buy
$16.00+29.3% to target
Coverage
—
+ Follow
#5
Richard Newitter
Truist Securities
Buy
$18.00+45.5% to target
Coverage
—
+ Follow
CARL stock forecast FAQ
What is CARL's average 12-month price target?+
The 5 analysts with a live target average $18.60 for Carlsmed, Inc. Common Stock over the next 12 months, ranging from a $23.00 high to a $17.00 low.
Is CARL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CARL?+
The Street-high target is $23.00 (BTIG), and the Street-low is $17.00 (Needham). The average of all 5 active targets is $18.60.
How many Wall Street analysts cover CARL?+
5 analysts have an active rating on Carlsmed, Inc. Common Stock, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering CARL?+
Among analysts who currently cover CARL, David Saxon of Needham has the strongest overall Quantellect track record (Rank #264). Their current call is Buy with a $17.00 target.
What is Carlsmed, Inc. Common Stock's projected EPS for next quarter?+
The consensus estimate is $-0.40 per share (range $-0.43 – $-0.36) across 2 analysts. Full-year EPS is projected at $-1.47, rising to $-1.44 the following year.
How much revenue is Carlsmed, Inc. Common Stock expected to report next quarter?+
Consensus revenue is $18.9M (range $18.4M – $19.4M). Full-year revenue is projected at $74.8M, growing to $105.0M next year.
Have analysts been upgrading or downgrading CARL lately?+
As of Jul, 5 of 5 firms rate CARL a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CARL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
